Search Within

Michael Forman Berger

Formats
  1. Meeting Abstract (425)
  2. Journal Article (326)
  3. Research Letter (9)
  4. Editorial (3)
  5. Guidelines (2)
  6. Review (2)
  7. Book Section (1)
  8. Conference Paper (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (769)
  2. Department of Pathology and Laboratory Medicine (769)
  3. GSK Faculty (769)
  4. Human Oncology and Pathogenesis Program (769)
  5. Department of Medicine (610)
  6. Solid Tumor Oncology Division (581)

More Groups

People
  1. David Solit (315)
  2. Marc Ladanyi (219)
  3. Ahmet Zehir (191)
  4. Maria Arcila (162)
  5. Nikolaus Schultz (157)
  6. Hikmat Al-Ahmadie (108)

More People

Years
  1. 2025 (19)
  2. 2024 (47)
  3. 2023 (55)
  4. 2022 (56)
  5. 2021 (40)
  6. 2020 (47)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer Research (67)
  3. Modern Pathology (65)
  4. Clinical Cancer Research (52)
  5. Laboratory Investigation (52)
  6. Journal of Molecular Diagnostics (38)

More Publications

Publishers
  1. American Society of Clinical Oncology (177)
  2. American Association for Cancer Research (145)
  3. Nature Publishing Group (111)
  4. Nature Research (68)
  5. Elsevier Science, Inc. (46)
  6. Oxford University Press (39)

More Publishers

Results (769)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cancer: The utility of detecting aberrant succination by immunohistochemistry
    Meeting Abstract

    Chen, Y. B.; Brannon, A. R.; Dudas, M. E.; Won, H.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A.; Frizzell, N.; Russo, P.; Berger, M. F.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
    Journal Article

    Wiesner, T.; He, J.; Yelensky, R.; Esteve-Puig, R.; Botton, T.; Yeh, I.; Lipson, D.; Otto, G.; Brennan, K.; Murali, R.; more...
    Nature Communications (2014)

    Fulltext@MSK | Save
  • Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: The role of massively parallel sequencing
    Journal Article

    De Mattos-Arruda, L.; Bidard, F. C.; Won, H. H.; Cortes, J.; Ng, C. K. Y.; Peg, V.; Nuciforo, P.; Jungbluth, A. A.; Weigelt, B.; Berger, M. F.; more...
    Molecular Oncology (2014)

    Fulltext@MSK | Save
  • Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis
    Journal Article

    Kiuru, M.; McDermott, G.; Coit, D. C.; Berger, M. F.; Busam, K. J.
    American Journal of Surgical Pathology (2014)

    Fulltext@MSK | Save
  • Treatment outcome with mTOR inhibitors for 65 cases of non-clear cell renal cell carcinoma: Association of long-term responses and oncogenomic events
    Meeting Abstract

    Voss, M. H.; Bastos, D. A.; Karlo, C.; Patil, S.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Molina, A. M.; Berger, M. F.; Hsieh, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Chen, Y.; Pham, C. G.; Brannon, A. R.; Scott, S. N.; Takeda, S.; Liu, H.; Motzer, R. J.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Next-generation sequencing of genomic and cDNA to identify a high frequency of kinase fusions involving ROS1, ALK, RET, NTRK1, and BRAF in Spitz tumors
    Meeting Abstract

    Stephens, P.; Wiesner, T.; He, J.; Yelensky, R.; Esteve-Puig, R.; Otto, G.; Berger, M. F.; Lipson, D.; Brennan, K.; Miller, V. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Patterns of metastasis and survival in patients with PI3K pathway-driven stage IV squamous cell lung cancers (SQCLC)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Won, H. H.; Hasanovic, A.; Rekhtman, N.; Sima, C. S.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Gromisch, C. M.; Kelsen, D. P.; Ku, G. Y.; Brown, K. T.; Schattner, M.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
    Meeting Abstract

    Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save